UniSA uses cookies to remember your preferences, analyse traffic, track usage patterns, and personalise content. In some instances, UniSA shares personal information collected by cookies with UniSA's third party service providers and Adelaide University (as UniSA's future successor). See our privacy notification for further details. To adjust your cookie settings, click 'More information'. By clicking 'Accept and continue', you consent to our use of cookies.
UniSA recommends the use of all cookies to provide you with the optimal experience while visiting our website. Choose below to accept the recommended settings or continue to adjust your individual preferences.
We undertake fundamental, translational and clinical research to explore novel immunotherapeutic approaches for cancer, allergy and other diseases including chronic and acute infections in both adult and paediatric populations. Using our broad range of expertise, we exploit the power and specificity of the immune system to develop cutting edge approaches to new diagnostics and therapeutic agents.
The Experimental Therapeutics Laboratory is a certified PC2 facility and is located at the City West campus. Our fully equipped laboratories and tissue culture suites feature state-of-the-art facilities and equipment which are routinely used to streamline workflow for developing next generation vaccines of the future.
We routinely utilise in vivo, ex vivo and in vitro models and a range of histological, virological, cellular and molecular techniques to explore the immune response to various stimulations, allowing us to target and design therapeutic and diagnostic agents for cancer, allergies and infection.